Overview
As Global Product Manager, you define and execute a multi-year roadmap for clinical flow cytometry routine IVD assays. You partner with cross-functional teams to shape product strategy, from market analysis to global launches, ensuring on-market performance and sustainable growth. You translate customer insights into compelling value propositions and collaborate with software, hardware, and marketing to deliver integrated workflows. You operate in a remote, matrixed environment, driving portfolio growth across geographies while addressing unmet needs. This role offers impact through shaping routine diagnostics at scale.
Responsibilities
- Define and execute a 3 to 5-year portfolio strategy and roadmap for clinical flow cytometry routine IVD assays.
- Lead end-to-end lifecycle management, including opportunity identification, market assessment, business case development, and launch planning.
- Translate customer and market insights into product requirements, value propositions, and go-to-market plans.
- Serve as voice of the customer throughout development to address pain points and deliver value in key market segments.
- Collaborate with software, hardware, and solution product managers to create integrated workflow solutions.
- Partner with Product Marketing and Commercial Marketing to maximize portfolio performance and successful launches.
- Generate market intelligence through competitive analysis and external partnerships to inform investment decisions and growth.
Key requirements
- 3+ years in product management, portfolio strategy, marketing or business development in IVD, Life Sciences, or medical device industries.
- Strong understanding of clinical flow cytometry workflows with ability to discuss technically with R&D, KOLs, and end users.
- Proven ability to lead complex initiatives across geographies and functions and influence cross-functional teams.
- Strategic, agile, results-oriented mindset with ability to manage multiple projects in ambiguity.
- interpersonal skills
- leadership across geographies
- influencing without direct authority
- clinical flow cytometry workflows
- market analysis
- portfolio lifecycle management
…
